DOCSLIB.ORG

Effect of the Buteyko Method on Resting Ventilation and Asthma Control in Asthma Patients

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Effect of the Buteyko Method on Resting Ventilation and Asthma Control in Asthma Patients Monique van Oosten Ritgerð til meistaragráðu Háskóli Íslands Læknadeild Námsbraut í Lýðheilsuvísindum Heilbrigðisvísindasvið Áhrif Buteyko aðferðinnar á hvíldaröndun og stjórnun astmasjúkdómsins hjá astmasjúklingum Monique van Oosten Ritgerð til meistaragráðu í Lýðheilsuvísindum Leiðbeinandi: Marta Guðjónsdóttir Meistaranámsnefnd: Marta Guðjónsdóttir, Auðna Ágústsdóttir og Björn Magnússon Læknadeild Námsbraut í Lýðheilsuvísindum Heilbrigðisvísindasvið Háskóla Íslands Mars 2017 Effect of the Buteyko Method on Resting Ventilation and Asthma Control in Asthma Patients Monique van Oosten Thesis for the degree of Master of Science Supervisor: Marta Guðjónsdóttir Masters committee: Marta Guðjónsdóttir, Auðna Ágústsdóttir and Björn Magnússon Faculty of Medicine Department of Public Health School of Health Sciences March 2017 Ritgerð þessi er til meistaragráðu í lýðheilsufræði og er óheimilt að afrita ritgerðina á nokkurn hátt nema með leyfi rétthafa. © Monique van Oosten 2017 Prentun: Háskólaprent Reykjavík, Ísland 2017 Ágrip Bakgrunnur . Buteyko meðferðin (BM) virðist breyta öndun, bæta lífsgæði og astma stjórnun hjá astma sjúklingum. Rannsóknir hafa fram að þessu ekki skilgreint nægilega vel lífeðlisfræðileg áhrif meðferðarinnar. Markmið þessarar rannsóknar er að skoða lífeðlisfræðileg áhrif BM á hvíldaröndun og stjórnun astma í hóp astmasjúklinga. Aðferð . Í þessari framskyggnu, íhlutandi rannsókn með samanburðarhópi voru astmasjúklingar mældir þrisvar sinnum í algjörri hvíld, með 6 mánaða millibili. Þeir voru paraðir miðað við aldur, kyn og líkamsþyngdarstuðul (BMI) við heilbrigðan samanburðahóp. BM var kennd eftir fyrstu 6 mánuðina. Síðan var hópnum fylgt eftir og mældur að nýju 6 mánuðum síðar. Hvíldaröndun (öndunartíðni og andrýmd (V T)), næmni öndunarstöðva metin út frá viljastýrðu öndunarstoppi, efnaskipti, og astma control spurningalisti (ACT) voru skoðuð. Hlutfall milli heildaröndunar (V´ E) og koltvísýringsútskilnaðar (V´ E/V´CO 2) var reiknað út. Fráblástursgeta á einni sekúndu (FEV 1) var mæld og reiknuð sem hlutfall af hámarksandrýmd (FEV 1/FVC). Niðurstöður : 22 (61%) af þeim 36 astmasjúklingum sem hófu rannsóknina og 20 þátttakendur í samanburðarhópi luku þátttöku. Í byrjum rannsóknarinnar voru hóparnir eins varðandi aldur, kyn og BMI, en FEV 1/FVC hlutfallið var lægra og viljastýrða öndunarstoppið styttra hjá astmahópnum (p<0.05). Eftir BM hjá astmahópnum hafði hlutþrýstingur koltvísýrings við lok útöndunar (P ET CO 2), V´ E/V´CO 2, og stig fyrir ACT aukist (p<0.05) og viljastýrða öndunarstoppið hafði lengst (p<0.001). Eins hafði hlutþrýstingur súrefnis við lok útöndunar (P ET O2), V´ E, VT og efnaskipti minnkað en BMI hafði hækkað (p<0.05). FEV 1/FVC var óbreytt. Umræða : Í upphafi var hvíldaröndun svipuð hjá hópunum en næmni öndunarstöðva var meiri hjá astmahópnum. BM virðist minnka næmni öndunarstöðva þar sem viljastýrða öndunarstoppið verður lengra. Hærra P ET CO 2 og lægra P ET O2 bendir til að hlutfall milli alveolar öndunar (V´ A) og V´CO 2 (V´ A/ V´CO 2) hafi minnkað, þrátt fyrir hærra V´ E/V´CO 2. Því má álykta að lægra V T hafi aukið öndun í dauðarýminu. BM bætir stjórnun á astma án þess að hafa breytt FEV 1/FVC. 3 4 Abstract Background : The Buteyko method (BM) seems to change breathing patterns, increase quality of life and asthma control in asthmatics. Until now, studies have not been able to identify sufficiently the physiological mechanism behind the BM. The aim of this study is to evaluate the physiological effect of BM on resting ventilation and asthma control in an asthma group. Methods : In this prospective, intervention study, asthmatics were measured 3 times at complete rest, at a 6-month interval. They were matched by age, gender, and body mass index (BMI) to control subjects. The first 6-month interval was the control period. The BM was taught to the asthmatics after the control period. Asthmatics were followed up and measured again after 6 months. Resting ventilation (respiratory rate and tidal volume (VT)), respiratory chemosensitivity evaluated by breath holding time (BHT) and metabolism were assessed, and the asthma control test questionnaire (ACT) was applied. The equivalent of pulmonary ventilation (V´ E) for carbon dioxide output (V´ E/V´CO 2) was calculated. The forced expiratory volume in one second (FEV 1) was measured and calculated as a percentage of the forced vital capacity (FEV 1/FVC). Results : 22 (61%) of 36 asthmatics and 20 control subjects finished the study. At baseline, groups were comparable regarding age, gender and BMI. In the asthma group, FEV 1/FVC was lower and BHT was shorter (p<0.05). After BM in the asthma group, partial pressure of end-tidal carbon dioxide (P ET CO 2), V´ E/V´CO 2, BMI and scores for the ACT had increased (p<0.05) and BHT had become longer (p<0.001). Partial pressure of end-tidal oxygen (P ET O2), V´ E, VT and metabolism had decreased (p<0.05). FEV 1/FVC remained the same. Discussion : At baseline, resting ventilation was alike between the groups, but respiratory chemosensitivity was higher in the asthma group as seen in shorter BHT. BM effected resting ventilation by decreasing respiratory chemosensitivity for CO 2 as evaluated by longer BHT. It could be concluded that the equivalent of alveolar ventilation (V´ A) for V´CO 2 (V´ A/V´CO 2) had decreased, evidenced by higher levels of P ET CO 2 and lower levels of P ET O2. However, V´ E/V´CO 2 had increased, implying greater dead space ventilation as a result of decreased V T. BM improved asthma control without altering FEV 1/FVC. 5 6 Acknowledgements First of all, I would like to express my deepest gratitude to my supervisor, Marta Guðjónsdóttir for carrying out this research project with me, and for all her guidance, support, encouragement, patience, and, most of all, her excellent teaching. I am very grateful to my master’s committee, Auðna Ágústsdóttir and Björn Magnússon, for supporting me in this work and for sharing their expertise. I am grateful to Reykjalundur for giving us the opportunity to perform our research in their laboratory. Finally, I would like to thank all my family and friends for their mental support, and last, but not least, my beloved daughter Katrín Möller, for her invaluable help. This project was financially supported by the Asthma and Allergy Foundation, the Icelandic Physiotherapy Society and the Oddur Ólafsson Foundation. 7 Table of contents Ágrip ........................................................................................................................................................ 3 Abstract .................................................................................................................................................... 5 Acknowledgements.................................................................................................................................. 7 Table of contents ..................................................................................................................................... 8 List of Figures ........................................................................................................................................ 10 List of tables ........................................................................................................................................... 11 List of abbreviations ............................................................................................................................... 12 1 Introduction .................................................................................................................................... 14 1.1 What is asthma? .................................................................................................................... 14 Diagnosis ................................................................................................................... 14 Risk factors and allergies ........................................................................................... 15 1.2 Asthma control ....................................................................................................................... 15 Control-based asthma management ......................................................................... 16 Psychological factors. ................................................................................................ 17 Posture and physical condition .................................................................................. 17 1.3 Ventilation at rest ................................................................................................................... 18 The Respiratory system ............................................................................................. 18 Pulmonary ventilation ................................................................................................ 22 Alveolar ventilation ..................................................................................................... 22 Dead space ventilation .............................................................................................. 23 The bicarbonate buffer system .................................................................................. 24 Spirometry.................................................................................................................. 25 Ventilation musculature ............................................................................................
Recommended publications
  • The Effect of Carbon Dioxide on Airway Tone

    The Effect of Carbon Dioxide on Airway Tone

    UNIVERSITY OF CALGARY The Effect of Carbon Dioxide on Airway Tone by Tamer Y. El Mays A THESIS SUBMITTED TO THE FACULTY OF GRADUATE STUDIES IN PARTIAL FULFILMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF SCIENCE DEPARTMENT OF CARDIOVASCULAR/RESPIRATORY SCIENCES CALGARY, ALBERTA April, 2007 © Tamer Y. El Mays 2007 UNIVERSITY OF CALGARY FACULTY OF GRADUATE STUDIES The undersigned certify that they have read, and recommend to the Faculty of Graduate Studies for acceptance, a thesis entitled “The Effect of Carbon Dioxide on Airway Tone" submitted Tamer Y. El Mays in partial fulfilment of the requirements of the degree of Master of Science. Supervisor, Dr. Francis HY Green, Dept. of Cardiovascular/Respiratory Sciences Dr. Marc J. Poulin, Dept. of Cardiovascular/Respiratory Sciences Dr. William A. Whitelaw, Dept. of Cardiovascular/Respiratory Sciences Dr. Richard J. Wilson, Dept. of Cardiovascular/Respiratory Sciences Dr. Neil Eves, Faculty of Kinesiology Date ii Abstract The Buteyko Breathing Technique (BBT) has received interest over the last few years as a non pharmacological complementary therapy for asthma. The BBT involves breath holding in order to raise PCO2 which is believed to result in broncho-relaxation and relief of asthma. Clinical trials indicate that asthmatics using BBT need less asthma medications. However, studies of the physiological basis for the theory have not yet been undertaken. The objective of this study was to determine the effects of inhaled CO2 on constricted airways in allergic asthma as well as evaluating the effects of CO2 on bronchial smooth muscle (BSM) tone in vitro. An animal model of acute on chronic asthma was developed using Brown Norway Rats immunized and challenged with ovalbumin.
  • Breathing Exercises And/Or Retraining Techniques in the Treatment of Asthma: Comparative Effectiveness Comparative Effectiveness Review Number 71

    Breathing Exercises And/Or Retraining Techniques in the Treatment of Asthma: Comparative Effectiveness Comparative Effectiveness Review Number 71

    Comparative Effectiveness Review Number 71 Breathing Exercises and/or Retraining Techniques in the Treatment of Asthma: Comparative Effectiveness Comparative Effectiveness Review Number 71 Breathing Exercises and/or Retraining Techniques in the Treatment of Asthma: Comparative Effectiveness Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 www.ahrq.gov Contract No. 290-2007-10057-I Prepared by: Oregon Evidence-based Practice Center Kaiser Permanente Center for Health Research Portland, OR Investigators: Elizabeth O’Connor, Ph.D. Carrie D. Patnode, Ph.D., M.P.H. Brittany U. Burda, M.P.H. David I. Buckley, M.D., M.P.H. Evelyn P. Whitlock, M.D., M.P.H. AHRQ Publication No. 12-EHC092-EF September 2012 This report is based on research conducted by the Oregon Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (Contract No. 290-2007-10057-I). The findings and conclusions in this document are those of the authors, who are responsible for its contents; the findings and conclusions do not necessarily represent the views of AHRQ. Therefore, no statement in this report should be construed as an official position of AHRQ or of the U.S. Department of Health and Human Services. The information in this report is intended to help health care decisionmakers—patients and clinicians, health system leaders, and policymakers, among others—make well-informed decisions and thereby improve the quality of health care services. This report is not intended to be a substitute for the application of clinical judgment.
  • For the Reversal of Chronic Hyperventilation

    For the Reversal of Chronic Hyperventilation

    For the Reversal of Chronic Hyperventilation By: Peter Kolb BSc(Eng), MSc(Med) Illustrations: Victor Lunn-Rockliffe Revision 1.2 Contents Page 1. What is Chronic Hyperventilation Syndrome? 3 2. How does CHV develop? 4 3. How does Buteyko therapy work? 4 4. What happens to patients with CHVS? 5 5. Physiological consequences of low CO2. 6 6. Immune system. 8 7. Other symptoms and disorders. 10 8. Buteyko for Asthma, 1st Clinical Trial. 12 9. Lung Function Test. 14 References 15 For more information: http://members.westnet.com.au/pkolb [email protected] 2 1. What is Chronic Hyperventilation Syndrome? Chronic Hyperventilation Syndrome [CHVS] is a vast complex of bizarre29,31,16 protean1,29,31,18 symptoms and disorders that are caused by habitually breathing too much. Technically it is not a syndrome at all since the symptoms are so variable. Not withstanding that chronic hyperventilation [CHV] has a compelling appeal as the physiological basis for the many chronic disorders we see today, mainstream medicine has consistently failed to deal with it since its discovery over 100 years ago.1,16,18,24,29 In 1975 British cardiologist, Claude Lum wrote:16 Some forty years ago Kerr, Dalton and Gliebe wrote "Patients presenting the well-known pattern of symptoms haunt the offices of physicians and specialists in every field of medical practice. They are often shunted from one physician to another, and the sins of commission inflicted upon them fill many black pages in our book of achievement.” Unfortunately I believe this to be still true today, despite the many and excellent reviews which have appeared in the intervening years.
  • Systematic Review of the Effectiveness of Breathing Retraining in Asthma Management

    Systematic Review of the Effectiveness of Breathing Retraining in Asthma Management

    Review For reprint orders, please contact [email protected] Systematic review of the effectiveness of breathing retraining in asthma management Expert Rev. Respir. Med. 5(6), 789–807 (2011) John Burgess1, In asthma management, complementary and alternative medicine is enjoying a growing Buddhini Ekanayake1, popularity worldwide. This review synthesizes the literature on complementary and alternative Adrian Lowe1, medicine techniques that utilize breathing retraining as their primary component and compares David Dunt2, evidence from controlled trials with before-and-after trials. Medline, PubMed, Cumulative Index 3 to Nursing and Allied Health Literature and the Cochrane Library electronic databases were Francis Thien and searched. Reference lists of all publications were manually checked to identify studies not found 1 Shyamali C Dharmage* through electronic searching. The selection criteria were met by 41 articles. Most randomized 1Centre for Molecular, Environmental, controlled trials (RCTs) of the Buteyko breathing technique demonstrated a significant decrease Analytic and Genetic Epidemiology, in b -agonist use while several found improvement in quality of life or decrease in inhaled Melbourne School of Population 2 Health, The University of Melbourne, corticosteroid use. Although few in number, RCTs of respiratory muscle training found a Victoria 3010, Australia significant reduction in bronchodilator medication use. Where meta-analyses could be done, 2Centre for Health Program Evaluation, they provided evidence of benefit from yoga, Buteyko breathing technique and physiotherapist- Melbourne School of Population led breathing training in improving asthma-related quality of life. However, considerable Health, The University of Melbourne, Victoria 3010, Australia heterogeneity was noted in some RCTs of yoga. It is reasonable for clinicians to offer qualified 3Department of Respiratory Medicine, support to patients with asthma undertaking these breathing retraining techniques.
  • Effectiveness of Buteyko Method in Asthma Control and Quality of Life of School-Age Children | 1

    Effectiveness of Buteyko Method in Asthma Control and Quality of Life of School-Age Children | 1

    Effectiveness of Buteyko Method in Asthma Control and Quality of Life of School-age Children | 1 Effectiveness of Buteyko Method in Asthma Control and Quality of Life of School-age Children Romella C. Lina, Matthew Daniel V. Leysa, Zarah DF. Libozada, Maria Francesca I. Lirio, Angelo A. Liwag, Gabriel D. Ramos, Margaret M. Natividad, RN, M.Ed. College of Nursing, University of Santo Tomas, España, Manila, Philippines 1015 ______________________________________________________________________________ ABSTRACT Background: Asthma affects not only the physiological status of school-age children but also their over- all functional capacity. This may eventually impede personality development if not managed promptly and adequately. Objective: This study aimed to determine the effectiveness of Buteyko Method in improving asthma control and quality of life of school-age children. Methods: This study utilized a pre-test – post test design to measure the changes in asthma control and quality of life after the administration of Buteyko Method. Fourteen (14) subjects diagnosed with bronchial asthma, age 7 - 11 years old participated in the study. They were equally divided into two groups: the control group received no intervention while the experimental group was asked to attend sessions of Buteyko Method lecture and demonstration. The experimental group was visited for three (3) consecutive weeks to monitor their progress and compliance. Moreover, each group was asked to answer ACQ pre- and post-intervention and PAQLQ before the start of the intervention phase and every week during the follow-up visits. Results: In comparing the asthma control pre-test and post-test mean scores of the control group, no significant difference was noted (p=0.177) while the experimental group showed a significant difference after the administration of Buteyko Method (p=0.002).